The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
The aldo-keto reductases (AKRs): Overview
Open accessAbstract
The aldo-keto reductase (AKR) protein superfamily contains > 190 members that fall into 16 families and are found in all phyla. These enzymes reduce carbonyl substrates such as: sugar aldehydes; keto-steroids, keto-prostaglandins, retinals, quinones, and lipid peroxidation byproducts. Exceptions include the reduction of steroid double bonds catalyzed by AKR1D enzymes (5β-reductases); and the oxidation of proximate carcinogen trans-dihydrodiol polycyclic aromatic hydrocarbons; while the (β-subunits of potassium gated ion channels (AKR6 family) control Kv channel opening. AKRs are usually 37 kDa monomers, have an (α/β)8-barrel motif, display large loops at the back of the barrel which govern substrate specificity, and have a conserved cofactor binding domain. AKRs catalyze an ordered bi bi kinetic mechanism in which NAD(P)H cofactor binds first and leaves last. In enzymes that favor NADPH, the rate of release of NADP+ is governed by a slow isomerization step which places an upper limit on kcat. AKRs retain a conserved catalytic tetrad consisting of Tyr55, Asp50, Lys84, and His117 (AKR1C9 numbering). There is conservation of the catalytic mechanism with short-chain dehydrogenases/reductases (SDRs) even though they show different protein folds. There are 15 human AKRs of these AKR1B1, AKR1C1-1C3, AKR1D1, and AKR1B10 have been implicated in diabetic complications, steroid hormone dependent malignancies, bile acid deficiency and defects in retinoic acid signaling, respectively. Inhibitor programs exist worldwide to target each of these enzymes to treat the aforementioned disorders. Inherited mutations in AKR1C and AKR1D1 enzymes are implicated in defects in the development of male genitalia and bile acid deficiency, respectively, and occur in evolutionary conserved amino acids. The human AKRs have a large number of nsSNPs and splice variants, but in many instances functional genomics is lacking. AKRs and their variants are now poised to be interrogated using modern genomic and informatics approaches to determine their association with human health and disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kumar, P., Henikoff, S., & Ng, P. C. (2009) · Nature Protocols · doi:10.1038/nprot.2009.86 · Cited by 6,521
PENNING, T. M., BURCZYNSKI, M. E., JEZ, J. M., HUNG, C.-F., LIN, H.-K., MA, H., MOORE, M., PALACKAL, N., & RATNAM, K. (2000) · Biochemical Journal · doi:10.1042/bj3510067 · Cited by 649
Self-citationComparative anatomy of the aldo–keto reductase superfamily
JEZ, J. M., BENNETT, M. J., SCHLEGEL, B. P., LEWIS, M., & PENNING, T. M. (1997) · Biochemical Journal · doi:10.1042/bj3260625 · Cited by 604
Self-citationThe Aldo-Keto Reductase Superfamily
Bohren, K. M., Bullock, B., Wermuth, B., & Gabbay, K. H. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60566-6 · Cited by 453
Wilson, D. K., Bohren, K. M., Gabbay, K. H., & Quiocho, F. A. (1992) · Science · doi:10.1126/science.1621098 · Cited by 432
Aldo-Keto Reductases and Bioactivation/Detoxication
Jin, Y., & Penning, T. M. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105337 · Cited by 383
Self-citationA new nomenclature for the aldo-keto reductase superfamily
Jez, J. M., Flynn, T. G., & Penning, T. M. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)84253-0 · Cited by 354
Self-citationThe backdoor pathway to dihydrotestosterone
Auchus, R. J. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.09.004 · Cited by 347
Hyperglycemia, Polyol Metabolism, and Complications of Diabetes Mellitus
Gabbay, K. H. (1975) · Annual Review of Medicine · doi:10.1146/annurev.me.26.020175.002513 · Cited by 329
The aldo-keto reductase superfamily homepage
Hyndman, D., Bauman, D. R., Heredia, V. V., & Penning, T. M. (2003) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00193-x · Cited by 314
Self-citation
Cited by
Cajigas, I., Chakraborty, A., Swyter, K. R., Luo, H., Bastidas, M., Nigro, M., Morris, E. R., Chen, S., VanGompel, M. J. W., Leib, D., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.07.024 · Cited by 82
Regulation of antioxidant defense and glyoxalase systems in cyanobacteria
Rai, R., Singh, S., Rai, K. K., Raj, A., Sriwastaw, S., & Rai, L. C. (2021) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2021.09.037 · Cited by 51
Han, X., Wu, X., Liu, F., Chen, H., & Hou, H. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117942 · Cited by 21
Decoding selectivity: computational insights into AKR1B1 and AKR1B10 inhibition
Liu, M., Qin, X., Li, J., Jiang, Y., Jiang, J., Guo, J., Xu, H., Wang, Y., Bi, H., & Wang, Z. (2024) · Physical Chemistry Chemical Physics · doi:10.1039/d3cp05985e · Cited by 7
Metadata
- Authors
- Penning, T. M.
- Venue
- Chemico-Biological Interactions
- Publisher
- Elsevier BV
- Published
- 2015-06
- Volume
- 234
- Pages
- 236-246
- ISSN
- 0009-2797 (ISSN-L)
- OpenAlex
- W2078086567
- Cited by
- 543
- References
- 80
- FWCI
- 9.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The aldo-keto reductases (AKRs): Overview. https://app.cochat.ai/papers/10.1016/j.cbi.2014.09.024
- The paper
- Penning, T. M. (2015). The aldo-keto reductases (AKRs): Overview. Chemico-Biological Interactions. https://doi.org/10.1016/j.cbi.2014.09.024
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.